Invert Graphite Limited has released a press release.
Submission of IND amendments for Phase II study
Filed with ASX ·
6ix hasn’t read this filing yet.
Invert Graphite Limited on 6ix
Earlier from Invert Graphite
- Completion of Manufacturing
- Appendix 4E - Preliminary Final Report
- Formation of Medical Advisory Board
- Shareholder Quarterly Update
- Appendix 4C March 2016 Quarter
Later from Invert Graphite
- FDA - lift of clincial hold
- Collaboration and IP option agreement with Monash University
- Phase II Clinical Trial - First Patient In
- Appendix 4C - December 2016 quarter
- Half Year Accounts
Follow Invert Graphite into a list and get an email when it puts out news.
Follow Invert Graphite